Stemtech Corp (STEK): Cost of Revenue
$566.9K
Year ended 2025-12-31
$545.5K
Trailing 12 months to 2026-06-30
-21.3%
3-year compound annual growth
-4.5%
5-year compound annual growth
| Period ended | Cost of Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $566.9K | -57.3% | 2026-05-29, From 2025-01-01 |
| 2024-12-31 | $1.33M | +32.4% | 2026-05-29, From 2024-01-01 |
| 2023-12-31 | $1.00M | -13.9% | 2025-06-30, From 2023-01-01 |
| 2022-12-31 | $1.16M | +13.8% | 2024-07-10, From 2022-01-01 |
| 2021-12-31 | $1.02M | +43.1% | 2023-04-17, From 2021-01-01 |
| 2020-12-31 | $715.2K | n/a | 2022-04-01, From 2020-01-01 |
Cost of Revenue at similar companies
| Company | Year ended | Cost of Revenue | Change YoY |
|---|---|---|---|
| Stemtech Corp (STEK) | 2025-12-31 | $566.9K | -57.3% |
| HWH International Inc. (ESYN) | 2025-12-31 | $407.2K | -37.5% |
| DataMeds AI, Inc. (MEDS) | 2025-12-31 | $29.76M | +81.9% |
| Cosmos Health Inc. (COSM) | 2025-12-31 | $57.38M | +14.5% |
| Nu Skin Enterprises, Inc. (NUS) | 2025-12-31 | $453.76M | -17.5% |
| Herbalife Ltd. (HLF) | 2025-12-31 | $1.11B | +0.9% |
| Cardinal Health Inc (CAH) | 2026-06-30 | $244.47B | +14.0% |
| Cencora, Inc. (COR) | 2025-09-30 | $309.85B | +9.1% |
| McKesson Corp (MCK) | 2026-03-31 | $388.88B | +12.5% |
Compare STEK, ESYN, MEDS, COSM side by side · Screen every company in Wholesale-Drugs, Proprietaries & Druggists' Sundries ↗